vs

Side-by-side financial comparison of Ballard Power Systems Inc. (BLDP) and RYTHM, Inc. (RYM). Click either name above to swap in a different company.

Ballard Power Systems Inc. is the larger business by last-quarter revenue ($17.7M vs $10.7M, roughly 1.7× RYTHM, Inc.). Ballard Power Systems Inc. runs the higher net margin — 994.4% vs -127.6%, a 1122.1% gap on every dollar of revenue.

Ballard Power Systems Inc. is a developer and manufacturer of proton exchange membrane (PEM) fuel cell products for markets such as heavy-duty motive, portable power, material handling as well as engineering services. Ballard has designed and shipped over 400 MW of fuel cell products to date.

RYTHM, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for rare genetic endocrine and metabolic disorders with high unmet medical needs. It primarily operates in the U.S. market, targeting pediatric and adult patient segments that lack standard effective treatment options.

BLDP vs RYM — Head-to-Head

Bigger by revenue
BLDP
BLDP
1.7× larger
BLDP
$17.7M
$10.7M
RYM
Higher net margin
BLDP
BLDP
1122.1% more per $
BLDP
994.4%
-127.6%
RYM

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BLDP
BLDP
RYM
RYM
Revenue
$17.7M
$10.7M
Net Profit
$176.5M
$-13.6M
Gross Margin
75.5%
Operating Margin
-121.5%
Net Margin
994.4%
-127.6%
Revenue YoY
242.0%
Net Profit YoY
44.1%
EPS (diluted)
$-6.78

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLDP
BLDP
RYM
RYM
Q4 25
$10.7M
Q3 25
$17.7M
$4.0M
Q2 25
$2.0M
Q1 25
$538.0K
Q4 24
$-7.5M
Q3 24
$-12.3M
$1.9M
Q2 24
$3.0M
Q1 24
$2.6M
Net Profit
BLDP
BLDP
RYM
RYM
Q4 25
$-13.6M
Q3 25
$176.5M
$-10.7M
Q2 25
$-7.4M
Q1 25
$-1.6M
Q4 24
$-24.4M
Q3 24
$-18.7M
Q2 24
$-3.0M
Q1 24
$4.2M
Gross Margin
BLDP
BLDP
RYM
RYM
Q4 25
75.5%
Q3 25
34.0%
Q2 25
33.4%
Q1 25
16.7%
Q4 24
Q3 24
156.5%
11.6%
Q2 24
37.6%
Q1 24
6.4%
Operating Margin
BLDP
BLDP
RYM
RYM
Q4 25
-121.5%
Q3 25
-219.8%
Q2 25
-332.9%
Q1 25
-687.9%
Q4 24
Q3 24
-63.1%
Q2 24
-28.5%
Q1 24
13.6%
Net Margin
BLDP
BLDP
RYM
RYM
Q4 25
-127.6%
Q3 25
994.4%
-263.8%
Q2 25
-360.4%
Q1 25
-302.2%
Q4 24
324.4%
Q3 24
-964.4%
Q2 24
-99.3%
Q1 24
163.0%
EPS (diluted)
BLDP
BLDP
RYM
RYM
Q4 25
$-6.78
Q3 25
$-5.33
Q2 25
$-3.74
Q1 25
$-0.83
Q4 24
$-24.26
Q3 24
$-17.28
Q2 24
$-3.16
Q1 24
$3.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLDP
BLDP
RYM
RYM
Cash + ST InvestmentsLiquidity on hand
$32.2M
Total DebtLower is stronger
$80.6M
Stockholders' EquityBook value
$13.0M
Total Assets
$106.7M
Debt / EquityLower = less leverage
6.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLDP
BLDP
RYM
RYM
Q4 25
$32.2M
Q3 25
Q2 25
$41.0M
Q1 25
$24.4M
Q4 24
Q3 24
$267.0K
Q2 24
$57.0K
Q1 24
$99.0K
Total Debt
BLDP
BLDP
RYM
RYM
Q4 25
$80.6M
Q3 25
$90.6M
Q2 25
$40.6M
Q1 25
$10.6M
Q4 24
Q3 24
$6.2M
Q2 24
$4.6M
Q1 24
Stockholders' Equity
BLDP
BLDP
RYM
RYM
Q4 25
$13.0M
Q3 25
$11.7M
Q2 25
$21.0M
Q1 25
$26.8M
Q4 24
$28.1M
Q3 24
$5.5M
Q2 24
$8.5M
Q1 24
$-5.5M
Total Assets
BLDP
BLDP
RYM
RYM
Q4 25
$106.7M
Q3 25
$115.2M
Q2 25
$69.5M
Q1 25
$45.6M
Q4 24
$54.0M
Q3 24
$39.0M
Q2 24
$39.4M
Q1 24
$40.6M
Debt / Equity
BLDP
BLDP
RYM
RYM
Q4 25
6.19×
Q3 25
7.73×
Q2 25
1.94×
Q1 25
0.40×
Q4 24
Q3 24
1.13×
Q2 24
0.54×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLDP
BLDP
RYM
RYM
Operating Cash FlowLast quarter
$5.7M
$-3.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.03×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLDP
BLDP
RYM
RYM
Q4 25
$-3.0M
Q3 25
$5.7M
$-5.4M
Q2 25
$-8.4M
Q1 25
$-6.7M
Q4 24
$-5.3M
Q3 24
$-6.6M
$-1.4M
Q2 24
$-1.8M
Q1 24
$-3.0M
Free Cash Flow
BLDP
BLDP
RYM
RYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$-1.8M
Q1 24
$-3.0M
FCF Margin
BLDP
BLDP
RYM
RYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-61.2%
Q1 24
-115.1%
Capex Intensity
BLDP
BLDP
RYM
RYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
BLDP
BLDP
RYM
RYM
Q4 25
Q3 25
0.03×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-0.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BLDP
BLDP

Segment breakdown not available.

RYM
RYM

Nonlicensing Revenue$9.5M89%
Cultivation Business Discontinued Operations$1.2M11%

Related Comparisons